Kimia Farma Persero Tbk Total Liabilities
Kimia Farma Persero Tbk total liabilities. Based on the latest financial reports, Kimia Farma Persero Tbk (KAEF) has total liabilities worth Rp11.91 Trillion IDR (≈ $697.78 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Kimia Farma Persero Tbk liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Kimia Farma Persero Tbk (2002–2025)
Total liabilities of Kimia Farma Persero Tbk from 2002 to 2025. This chart illustrates how Kimia Farma Persero Tbk's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Kimia Farma Persero Tbk's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Kimia Farma Persero Tbk Competitors by Total Liabilities
The table below lists competitors of Kimia Farma Persero Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Anavex Life Sciences Corp
NASDAQ:AVXL
|
USA | $7.69 Million |
|
Min Aik Technology Co Ltd
TW:3060
|
Taiwan | NT$1.76 Billion |
|
Jw Life Science Corp
KO:234080
|
Korea | ₩79.02 Billion |
|
Asuransi Multi Artha Guna Tbk PT
JK:AMAG
|
Indonesia | Rp3.46 Trillion |
|
TCM Group
CO:TCM
|
Denmark | Dkr764.30 Million |
|
LifeMD Inc
NASDAQ:LFMD
|
USA | $47.25 Million |
|
Honghua Group Limited
F:4HB
|
Germany | €8.97 Billion |
|
Sidus Space Inc
NASDAQ:SIDU
|
USA | $5.96 Million |
Liability Composition Analysis (2002–2025)
This chart breaks down Kimia Farma Persero Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see KAEF total assets.
Liquidity & Leverage Metrics
Kimia Farma Persero Tbk Total Liabilities Ratios Explained
Kimia Farma Persero Tbk total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.81 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kimia Farma Persero Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kimia Farma Persero Tbk (2002–2025)
The table below shows the annual total liabilities of Kimia Farma Persero Tbk from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Rp11.67 Trillion ≈ $684.01 Million |
+1.17% |
| 2024-12-31 | Rp11.54 Trillion ≈ $676.09 Million |
+3.09% |
| 2023-12-31 | Rp11.19 Trillion ≈ $655.84 Million |
+1.62% |
| 2022-12-31 | Rp11.01 Trillion ≈ $645.42 Million |
+4.62% |
| 2021-12-31 | Rp10.53 Trillion ≈ $616.92 Million |
+0.68% |
| 2020-12-31 | Rp10.46 Trillion ≈ $612.75 Million |
-4.41% |
| 2019-12-31 | Rp10.94 Trillion ≈ $641.04 Million |
+79.23% |
| 2018-12-31 | Rp6.10 Trillion ≈ $357.67 Million |
+73.23% |
| 2017-12-31 | Rp3.52 Trillion ≈ $206.47 Million |
+50.51% |
| 2016-12-31 | Rp2.34 Trillion ≈ $137.18 Million |
+70.37% |
| 2015-12-31 | Rp1.37 Trillion ≈ $80.52 Million |
+18.76% |
| 2014-12-31 | Rp1.16 Trillion ≈ $67.80 Million |
+36.51% |
| 2013-12-31 | Rp847.58 Billion ≈ $49.67 Million |
+33.52% |
| 2012-12-31 | Rp634.81 Billion ≈ $37.20 Million |
+17.18% |
| 2011-12-31 | Rp541.74 Billion ≈ $31.74 Million |
-0.28% |
| 2010-12-31 | Rp543.26 Billion ≈ $31.83 Million |
-4.24% |
| 2009-12-31 | Rp567.31 Billion ≈ $33.24 Million |
+13.94% |
| 2008-12-31 | Rp497.91 Billion ≈ $29.18 Million |
+4.01% |
| 2007-12-31 | Rp478.71 Billion ≈ $28.05 Million |
+22.57% |
| 2006-12-31 | Rp390.57 Billion ≈ $22.89 Million |
+17.15% |
| 2005-12-31 | Rp333.38 Billion ≈ $19.53 Million |
-7.10% |
| 2004-12-31 | Rp358.85 Billion ≈ $21.03 Million |
-41.39% |
| 2003-12-31 | Rp612.31 Billion ≈ $35.88 Million |
+69.50% |
| 2002-12-31 | Rp361.25 Billion ≈ $21.17 Million |
-- |
About Kimia Farma Persero Tbk
PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Others segments. The company offers drugs in the form of tablets, effervescent tablets, hard and soft capsules, liquids, syrups, oral powders, non-beta-lactam external liquids, beta-lactam tablets and dry syrup… Read more